Gilder Gagnon Howe & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8
Closed 364
2021
Q4
$0 Hold
8
﹤0.01% 451
2021
Q3
$0 Hold
8
﹤0.01% 449
2021
Q2
$0 Hold
8
﹤0.01% 453
2021
Q1
$0 Hold
8
﹤0.01% 414
2020
Q4
$0 Hold
8
﹤0.01% 361
2020
Q3
$0 Hold
8
﹤0.01% 354
2020
Q2
$0 Hold
8
﹤0.01% 322
2020
Q1
$0 Hold
8
﹤0.01% 311
2019
Q4
$0 Hold
8
﹤0.01% 311
2019
Q3
$0 Buy
+8
New +$148 ﹤0.01% 308

Other funds holding CVET

Gilder Gagnon Howe & Co's CVET Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2022, closing a stake of 8 shares.

Gilder Gagnon Howe & Co first reported a position in CVET in Q3 2019 and held it in 10 quarters. The position peaked at $0 in Q4 2021. 257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

  • Gilder Gagnon Howe & Co reported no remaining Covetrus, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 8 Covetrus, Inc. Common Stock shares in Q1 2022.
  • Gilder Gagnon Howe & Co first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • Gilder Gagnon Howe & Co's Covetrus, Inc. Common Stock position peaked at $0 in Q4 2021.
  • 257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.